 NEWARK, Calif., April 20, 2022 GLOBE NEWSWIRE -- Rain Therapeutics Inc. NasdaqGS: RAIN, Rain, a late-stage company developing precision oncology therapeutics, today announced it will report financial results for the first quarter ended March 31, 2022 and highlights of recent progress on Wednesday, May 4, 2022. On that day, management will host a conference call and webcast at 2:00 pm PT 5:00 pm ET to discuss the Companys business and financial results. 